FM1® Test
← Back to Blog

Fibromyalgia Clinical Trials: How to Find, Qualify and Join

Abstract pathway representing clinical trial participation

You can join a fibromyalgia clinical trial if you meet a study’s criteria, and taking part usually costs you nothing out of pocket. Most trials ask for a confirmed fibromyalgia diagnosis, an adult age range and a minimum pain level, and they exclude people with certain other conditions. The fastest way to find one is the federal registry ClinicalTrials.gov. A documented diagnosis makes screening faster. This guide covers what trials study today, how they run, who qualifies, what you give and get, and how to check that a study is real.

Fm1test
fm1test.com
Find Evidence for Fibromyalgia
The FM1® Test uses a blood sample to identify DNA genomic signatures related to fibromyalgia, chronic pain and fatigue.
Visit the FM1® Test

TL;DR

  • Fibromyalgia trials test drugs, devices, exercise programs, brain stimulation and psychedelic-assisted approaches. Search them on ClinicalTrials.gov, the NIH-linked registry.
  • Typical entry rules: adults, often 18 to 65, a diagnosis that meets the 2016 ACR criteria, and a minimum pain score. Other illnesses can exclude you.
  • Taking part usually costs nothing, and many studies pay for your time and travel. Expect more visits and blood draws than routine care.
  • Check that a study has IRB approval and a registry listing before you share personal information.
  • Our FM1® Test is a blood test that we designed to identify DNA genomic signatures in fibromyalgia. We offer a no-cost clinical trial to people who test positive.

Table of Contents

What fibromyalgia trials are studying right now

Research has moved quickly. A 2026 genetic study in Nature Medicine pooled 2,563,755 people (54,629 cases and 2,509,126 controls) and found 26 risk loci. The authors found the heritability concentrated in brain tissues and neural cell types, and they describe fibromyalgia as a central nervous system disorder. A Nature Reviews Rheumatology commentary says this map gives researchers targets they can test. It also leaves open questions about immune involvement, sex differences and ancestry gaps.

That science shapes what trials look like. The main categories:

Medications

A large 2026 network meta-analysis of 151 randomized trials covered 32,592 participants. It found that no drug had moderate or high certainty evidence of important improvement in core outcomes. Low certainty evidence suggested that sodium oxybate, selective NRIs, SNRIs and gabapentinoids may help more people report meaningful improvement. This is a reason why new studies keep looking for better options.

Examples of active designs include a low-dose metformin study run at the University of Utah (the INFORM trial, described below) and a psilocybin trial registered in the Netherlands. The psilocybin trial is double-blind and placebo-controlled with 35 patients. It compares placebo with 5 mg and 10 mg doses and measures pain perception with a cold pressor test and a pressure threshold task.

Devices and brain stimulation

The NIH’s arthritis and musculoskeletal institute reports that trials are testing transcranial electrical stimulation. Others are assessing light, music, exercise or heat therapy, and nutritional supplements, for pain and sleep. The completed TIPS pragmatic trial enrolled 459 patients across six healthcare systems. It tested whether adding TENS to routine physical therapy reduces movement-evoked pain at 60 days.

Exercise and rehabilitation

A 2026 scoping review from Sheffield Hallam University covered 79 articles. It found that people with fibromyalgia show lower strength, fitness, balance and flexibility than healthy controls. Progressive resistance exercise looked promising for quality of life, but study designs varied too much to compare. A published protocol for the FIBROIA trial tests a 12-week program of AI-guided exercise sessions three times a week plus weekly pain education in 50 adults.

Emerging approaches

A 2026 review in Clinical and Experimental Rheumatology describes preliminary evidence for cannabinoids and neuromodulatory agents. Psilocybin and other psychedelics are in early phase studies. Non-invasive brain stimulation and vagal nerve stimulation are also emerging. The review’s overall conclusion is that a multimodal approach combining drug and non-drug strategies fits the evidence best.

The American Fibromyalgia Syndrome Association’s research update adds lab-based work. It covers a marker that maps widespread pain and documents brain inflammation. Antibodies from patients lowered the pain threshold in mice. Patient neutrophils increased pain sensitivity in mice. Gut bacteria from patients also lowered the pain threshold in mice.

How a fibromyalgia clinical trial works

Every trial follows the same basic path: you find it, you are screened, you give informed consent, you take part in scheduled visits, and you are followed up afterward. The details differ a lot, so read the actual protocol.

Five stages of joining a clinical trial

A short, simple example. The NIH-funded INFORM trial at the University of Utah tests low-dose metformin. Participants make four study visits over about 9 weeks. They take metformin or placebo once daily for 8 weeks, complete phone-based symptom surveys and give blood samples. People who complete it are compensated for their time.

A longer example. The University of Michigan’s Phase 2a psilocybin study runs about 8 months from screening to last follow-up. It has a 42-day screening period, three weeks of baseline and preparation, two dosing sessions, integration visits, and follow-ups at 3 and 6 months. A Safety Review Committee monitors participants continuously.

A mid-length example. A Maastricht University consent form describes about five weeks, five in-person visits, questionnaires, computer tasks and blood draws totaling roughly 190 ml.

So the commitment ranges from a few weeks to most of a year. Placebo-controlled trials mean you may not know whether you received the active treatment until the study ends.

Who qualifies: fibromyalgia trial eligibility

Eligibility rules are written into each study, and they exist to protect you and to keep results clean. Common patterns from the studies above:

Criterion Typical example
Age 18 to 65 (INFORM and the Maastricht psilocybin trial both use this range)
Diagnosis Meeting the ACR criteria for fibromyalgia (2016 version in INFORM and FIBROIA)
Pain level A minimum score, for example at least 5 out of 10 on a numeric rating scale
Body size Some studies set a BMI range, such as 18 to 28 kg/m²
Language Fluency in the study’s language, such as Dutch or English

Exclusions are just as important. The INFORM exclusion list includes uncontrolled or unstable illness, a co-occurring progressive disease such as cancer, pregnancy or planning pregnancy within the next year, and diabetes requiring medical therapy. It also lists autoimmune disease, cardiovascular, liver, kidney or lung disease, psychosis or a psychiatric admission in the past year, substance abuse in the past year, acute or neuropathic pain, and weight-control medications.

If an exclusion applies to you, it does not mean something is wrong with you. Another trial may fit. Each one sets its own rules.

What screening involves

Screening usually starts with a phone or online questionnaire. It continues with a review of your medical history and medications. It may include an in-person visit with exams or blood work. Bring a list of your current medications and any records of your diagnosis. A documented, objective result can help the study team confirm that you meet the entry criteria.

Costs, pay and time: what to expect

Trial participation generally does not cost you for the study procedures. Many studies compensate you. The Maastricht study pays €225 (based on €10 an hour plus a €15 bonus for completing all conditions) and reimburses public transport. A Danish low-dose naltrexone protocol reimburses travel at 1.97 DKK per kilometer for participants living more than 25 kilometers away. These are examples, and US studies set their own amounts, so ask the study coordinator what is covered.

Time is the real cost. The NHLBI notes that trials may require more time and attention than standard treatment: extra site visits, more blood tests and procedures, or complex dosing schedules.

A 2024 survey of 436 women with fibromyalgia found that 56% were very likely to take part in randomized trials. The barriers that reduced willingness were fear of side effects, distance to the trial center, the number of visits, the chance of placebo and the institution’s reputation. If those worry you, ask about them at the start. Choose studies with fewer visits, nearby sites or remote components.

Costs, pay and time: what to expect

Benefits and risks, in plain terms

Possible benefits. The NHLBI says well-designed trials can give you access to new treatments before they are widely available, along with careful, regular attention from a research team of doctors and other professionals. You also contribute to the science that may help others with fibromyalgia.

Possible risks. The same source lists minor discomfort, complications that need medical attention and, rarely, serious or life-threatening complications from experimental treatments. In a placebo-controlled trial you may receive no active treatment, and there is no guarantee your symptoms will improve.

Before you decide, talk to your own doctor, especially if you take other medications or have another condition. Ask the study team these questions:

  1. What is being tested, and what is the chance I receive placebo?
  2. How many visits are there, and how long is each?
  3. What side effects have been seen so far?
  4. What costs are covered, and what happens if I am injured?
  5. Can I leave at any time, and will my regular care continue?

How to find a trial and check that it is legitimate

Start with ClinicalTrials.gov. It is a searchable registry and results database of federally and privately supported studies in the US and around the world. Each listing gives the purpose, who may participate, locations and contact numbers. Search “fibromyalgia,” filter to recruiting studies and narrow by state or distance. University pain centers and academic hospitals also post their own current studies.

The NIH points out that a listing does not mean the federal government has evaluated the study. Talk to your health care provider before you take part.

A quick legitimacy check:

  • A registry number. Legitimate studies carry an NCT number you can look up.
  • IRB approval. An institutional review board must approve the study, and the consent form should name it.
  • A named sponsor and investigator. A university, hospital or company you can verify.
  • No fee to join. Be wary of any study that asks you to pay to participate.
  • A written consent form. You should get time to read it and ask questions before you sign.

Can a trial or a research test confirm fibromyalgia?

For years, diagnosis rested on symptoms and clinical exams. The NIH institute says researchers are working to develop imaging and laboratory tests that distinguish fibromyalgia from other pain conditions. That could help doctors avoid treating fibromyalgia pain with opioids, which are potentially addictive and ineffective for the disorder. Objective testing is an active research goal, and it is why people with long, unexplained pain look for a measurable result.

What we think about trials and objective testing

Many people reach a trial after years of being told their pain was stress or in their head. We built our work around the idea that you deserve objective evidence. The FM1® Test uses DNA science to look for immune system changes that we have linked to fibromyalgia, chronic pain and fatigue. In our view, a clear result changes the conversation with your doctor, your family and your insurer.

We also believe research moves forward when patients take part. That is why we offer a no-cost clinical trial to people who test positive. A test result and a research opportunity work together: one gives you an answer, and the other lets that answer help the next patient.

If you are considering any trial, start with the facts: your diagnosis, your medications and the study’s criteria. Then ask questions until you are comfortable.

the author

Get a clear result with the FM1® Test

If you want objective information before you look for a study, the FM1® Test is a blood test that we designed to identify DNA genomic signatures in patients with fibromyalgia. It needs only a blood draw at a local facility. Results typically come back within about a week. We state that the test is covered by Medicare and by insurance. People who test positive are eligible for our no-cost clinical trial.

Fm1test

You can learn more and start at fm1test.com.

FAQ

Do I have to pay to join a fibromyalgia clinical trial?

Usually not for the study procedures. Many studies also pay you for your time or reimburse travel, though amounts vary. Ask the coordinator exactly what is covered, including parking and travel, before you enroll.

What are the usual eligibility rules?

Most studies require adults, often 18 to 65, with a diagnosis that meets the ACR criteria and a minimum pain score. Other conditions such as autoimmune, heart, liver or kidney disease, pregnancy or recent psychiatric admission often exclude people. Each study lists its own rules on its registry page.

How do I know a trial is legitimate?

Look it up on ClinicalTrials.gov by its NCT number and confirm that an IRB has approved it. Check that the sponsor is a real institution and that you are never asked to pay to join. Talk to your doctor before you sign the consent form.

Will I get the real treatment or a placebo?

In many trials some participants receive a placebo or sham treatment, and you may not know which until the end. The consent form explains the chances of each. Ask whether participants in the placebo group are offered the active treatment afterward.

Can I leave a trial if I change my mind?

Yes. Participation is voluntary, and you can ask to stop at any time. Tell the study team why, especially if you have side effects, so they can look after your health.

Sources

Made with BabyLoveGrowth’s AI tools

Apply Now